| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
* Division of Rheumatology, Department of Medicine, University of Pennsylvania, and
Laboratory of Dendritic Cell Biology, Division of Rheumatology, Department of Pediatrics, The Children’s Hospital of Philadelphia, Philadelphia, PA 19104; and
Department of Microbiology and Immunology, Temple University School of Medicine, Philadelphia, PA 19140
Autoreactivity in lupus requires the delivery of autoantigens to APCs in a proinflammatory context. It has been proposed that apoptotic cells are a source of lupus autoantigens and targets for autoantibodies. Using a histone H2B-GFP fusion protein as traceable Ag, we show here that lupus autoantibodies, directed against nuclear autoantigens, can opsonize apoptotic cells, enhance their uptake through induction of proinflammatory Fc
R-mediated phagocytosis, and augment Ag-specific T cell proliferation by increasing Ag loading. Apoptotic blebs and bodies seemed to be a preferred target of DC phagocytosis, via both "eat-me signals" and FcR-mediated mechanisms; furthermore, inhibition of nuclear Ag redistribution, by blockade of chromatin fragmentation, could stop binding and opsonization of apoptotic cells by autoantibodies, and inhibited Fc-R-mediated enhancement of phagocytosis. Our results suggest that DC uptake of opsonized histones and other nuclear Ags from apoptotic cells is a novel pathway for the presentation of nuclear Ags in a highly inflammatory context. Blockade of chromatin fragmentation in lupus is a potential therapeutic approach, which could theoretically limit DC access to autoantigens delivered in proinflammatory context, while leaving available for tolerization those delivered in a noninflammatory context.
This article has been cited by other articles:
|
|
 |
|
  G E Grossmayer, L E Munoz, C K Weber, S Franz, R E Voll, P M Kern, J R Kalden, G Schett, M Herrmann, and U S Gaipl IgG autoantibodies bound to surfaces of necrotic cells and complement C4 comprise the phagocytosis promoting activity for necrotic cells of systemic lupus erythaematosus sera Ann Rheum Dis, November 1, 2008; 67(11): 1626 - 1632. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Munoz, C van Bavel, S Franz, J Berden, M Herrmann, and J van der Vlag Apoptosis in the pathogenesis of systemic lupus erythematosus Lupus, May 1, 2008; 17(5): 371 - 375. [Abstract] [PDF]
|
|
|
|
|
|
S Muller, J Dieker, A Tincani, and P. Meroni Pathogenic anti-nucleosome antibodies Lupus, May 1, 2008; 17(5): 431 - 436. [Abstract] [PDF]
|
|
|
|
 |
|
 T. L. McGaha, M. C. I. Karlsson, and J. V. Ravetch Fc{gamma}RIIB Deficiency Leads to Autoimmunity and a Defective Response to Apoptosis in Mrl-MpJ Mice J. Immunol., April 15, 2008; 180(8): 5670 - 5679. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Frisoni, L. McPhie, S.-A. Kang, M. Monestier, M. Madaio, M. Satoh, and R. Caricchio Lack of Chromatin and Nuclear Fragmentation In Vivo Impairs the Production of Lupus Anti-Nuclear Antibodies J. Immunol., December 1, 2007; 179(11): 7959 - 7966. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Johansson, L. Walther-Jallow, A. Smed-Sorensen, and A.-L. Spetz Triggering of Dendritic Cell Responses after Exposure to Activated, but Not Resting, Apoptotic PBMCs J. Immunol., August 1, 2007; 179(3): 1711 - 1720. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
